european end-to-end CDMO company, pharma services
  • About us
    • History
    • Leaderships
    • Team
    • EU grants
    • Requests for Proposal
    • Sustainability – ESG
    • Bussines strategy
    • Quality policy
    • Virtual Tour
  • Services
    • Drug Substance Manufacturing
    • Fill & Finish
    • Gene to Vial: End-to-End Development
    • Process Development
    • Analytics 
    • Cell Line Development & Banking
  • Science Hub
    • Science News
    • Resources
  • News & Events
    • Press releases
    • Events
    • Content to download
  • Investors
    • Corporate documents
    • Shareholders and shares
    • Periodic reports
    • Current reports
    • Sustainability reports
    • Corporate governance at Mabion
    • Financial data
    • For Investors
    • Calendar
  • Contact us
    • Contact form
    • Contact for investors
    • Contact for media
    • Careers
  • EN
  • Science News
  • Resources

Contamination

biofilm risks in water systems

Risk Management Strategies for Biofilms in Water Systems used in Sterile Drug Manufacturing

Contamination, Regulatory

Rapid Microbiological Methods (RMMs) enhance sterile drug quality control

Rapid Microbiological Methods in Quality Control of Sterile Drugs

Contamination, Drug product, Microbiology

MALDI-TOF mass spectrometry

MALDI-TOF MS Techniques in Microbial Identification

Bioanalytics, Contamination, Microbiology

Mycoplasma Contamination Risks in Biomanufacturing

Mycoplasma contamination in biopharmaceutical manufacturing

Biologics, Cell culture, Contamination, Manufacturing

Contact

Find out how we may support your business.

bd@mabion.eu

Mabion

gen. Mariana Langiewicza 60
95-050 Konstantynów Łódzki
Poland

+48 42 207 78 90

    Mabion
    • Privacy policy
    • Services
    • Investors
    • News&Events
    • Contact us

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Page Sitemap

    Powered by

    Veneo